Proteasome InhibitionIn VivoPromotes Survival in a Lethal Murine Model of Severe Acute Respiratory Syndrome
- 1 December 2010
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 84 (23), 12419-12428
- https://doi.org/10.1128/jvi.01219-10
Abstract
Ubiquitination is a critical regulator of the host immune response to viral infection, and many viruses, including coronaviruses, encode proteins that target the ubiquitination system. To explore the link between coronavirus infection and the ubiquitin system, we asked whether protein degradation by the 26S proteasome plays a role in severe coronavirus infections using a murine model of SARS-like pneumonitis induced by murine hepatitis virus strain 1 (MHV-1). In vitro, the pretreatment of peritoneal macrophages with inhibitors of the proteasome (pyrrolidine dithiocarbamate [PDTC], MG132, and PS-341) markedly inhibited MHV-1 replication at an early step in its replication cycle, as evidenced by inhibition of viral RNA production. Proteasome inhibition also blocked viral cytotoxicity in macrophages, as well as the induction of inflammatory mediators such as IP-10, gamma interferon (IFN-gamma), and monocyte chemoattractant protein 1 (MCP-1). In vivo, intranasal inoculation of MHV-1 results in a lethal pneumonitis in A/J mice. Treatment of A/J mice with the proteasome inhibitor PDTC, MG132, or PS-341 led to 40% survival (P < 0.01), with a concomitant improvement of lung histology, reduced pulmonary viral replication, decreased pulmonary STAT phosphorylation, and reduced pulmonary inflammatory cytokine expression. These data demonstrate that inhibition of the cellular proteasome attenuates pneumonitis and cytokine gene expression in vivo by reducing MHV-1 replication and the resulting inflammatory response. The results further suggest that targeting the proteasome may be an effective new treatment for severe coronavirus infections.This publication has 57 references indexed in Scilit:
- The Proteasome Inhibitor Velcade Enhances rather than Reduces Disease in Mouse Hepatitis Coronavirus-Infected MiceJournal of Virology, 2010
- The Ubiquitin-Proteasome System Plays an Important Role during Various Stages of the Coronavirus Infection CycleJournal of Virology, 2010
- A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replicationProceedings of the National Academy of Sciences of the United States of America, 2008
- Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumorsNature Medicine, 2008
- Human Coronavirus 229E Papain-Like Proteases Have Overlapping Specificities but Distinct Functions in Viral ReplicationJournal of Virology, 2007
- Membrane topology of murine coronavirus replicase nonstructural protein 3Virology, 2007
- MurineHepatitis Virus Strain 1 Produces a Clinically Relevant Model of Severe Acute Respiratory Syndrome in A/J MiceJournal of Virology, 2006
- Severe acute respiratory syndrome coronavirus papain-like protease: Structure of a viral deubiquitinating enzymeProceedings of the National Academy of Sciences, 2006
- Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilizationNature, 2002
- A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory proteinThe EMBO Journal, 1997